language_icon
EN
HI

Strides Pharma Science Share price

STAR

903.65

6.05 (0.67%)
NSE
BSE
Last updated on 20 Mar, 2026 | 15:31 IST
Today's High

921.25

Today's Low

897.60

52 Week Low

513.05

52 Week High

1025.00

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Strides Pharma Science Chart

Strides Pharma Science Share Key Metrics

Volume
2.47 L
Market Cap
8329.19 CR
LTQ@LTP
2@903.65
ATP
908.92
Var Margin
21.24 %
Circuit Range
718.1-1077.1
Delivery %
40.93 %
Value
22.41 CR
ASM/GSM
No
Market Lot
1

Summary

At 20 Mar, 2026 | 15:31, Strides Pharma Science share price stands at ₹903.65, showing a 6.05% 0.67 for the day. The stock’s intraday movement has stayed between ₹897.60 and ₹921.25, while on a 52-week basis it has fluctuated from ₹513.05 to ₹1025.00.
In terms of trading activity, Strides Pharma Science has recorded a volume of 246535 shares, with a market capitalisation of ₹92172714. The stock’s Average Traded Price (ATP) stands at ₹90892, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 2,90365. The stock operates within a circuit range of ₹718.1-1077.1, with a Value of ₹22.41 CR. The Delivery Percentage for the day is 40.93%. Additionally, Strides Pharma Science currently falls under the No framework, and trades with a market lot size of 1.

Strides Pharma Science Fundamentals

View More
P/E Ratio

16.17

P/B Ratio

2.79

Div. Yield

0.45

Sector P/E

59.61

Sector P/B

2.6

Sec. Div. Yield

0.59

Strides Pharma Science Resistance and Support

Pivot 901.45

Resistance

First Resistance

912.4

Second Resistance

927.2

Third Resistance

938.15

Support

First Support

886.65

Second Support

875.7

Third Support

860.9

Strides Pharma Science Futures & Options

Data Not Found

Strides Pharma Science Shareholding Pattern

View More
  • 2018-19
  • 2019-20
  • 2020-21
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
Total Promoters
Segment
Percent

Total Promoters

27.86%

Mutual Fund

8.59%

Insurance

3.05%

Foreign Institutional Investors

29.52%

Domestic Institutional Investors

1.39%

Retail

29.59%

Others

0%

Total Promoters
MAR '25
28.3%
JUN '25
28.3%
SEP '25
27.86%
DEC '25
27.86%

Strides Pharma Science Corporate Actions

DateAgenda
2026-01-30Quarterly Results
2025-10-31Quarterly Results
2025-07-29Quarterly Results
2025-05-22Audited Results & Final Dividend
2025-01-30Quarterly Results

Strides Pharma Science News

Strides Pharma Science Limited

Strides Pharma International AG acquired and in-licensed multiple generic brands from Sandoz for USD 12 million, expanding its footprint in Sub-Saharan Africa. This strategic move aims to position Strides Pharma among the top five pharmaceutical companies in the region by sales, covering key markets like Ghana and Nigeria.
Mar 17 2026 18:03:00

Strides Pharma Science Limited

Strides Pharma International AG acquired and in-licensed multiple generic brands from Sandoz for USD 12 million, expanding its footprint in Sub-Saharan Africa. This strategic move aims to position Strides Pharma among the top five pharmaceutical companies in the region by sales, covering key markets like Ghana and Nigeria.
Mar 17 2026 18:03:00
Read More

About Strides Pharma Science

NSE : 7374  
BSE : 532531  
ISIN : INE939A01011  

Strides Pharma Science Management

NamePosition
Mr. Arun Kumar Non Executive Chairperson
Mr. Ameet Hariani Non Executive Chairperson
View More

Strides Pharma Science FAQs

The Buying Price of Strides Pharma Science share is 903.65 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Strides Pharma Science stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Strides Pharma Science, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Strides Pharma Science shares is 16.17. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Strides Pharma Science shares is 2.79. Useful to assess the stock's value relative to its book value.

To assess Strides Pharma Science’s valuation compare Sector P/E, P/B which are 59.61 & 2.6 with sector averages, along with growth rates and financial metrics.

The Market Cap of Strides Pharma Science is 8329.19 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Strides Pharma Science share price is 1025.00 & 513.05. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Strides Pharma Science belongs to the Healthcare sector.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost